Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Group by: Date | Item Type
Jump to: Article | Review

Article

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N., Ellenberger, D., Stahmann, A., Fneish, F., Lüftenegger, D., Salmen, H.C., Schirduan, K., Schaak, T.P.A., Flachenecker, P., Kleinschnitz, C., Paul, F., Krefting, D., Zettl, U.K., Peters, M. and Warnke, C.
Therapeutic Advances in Neurological Disorders 17 : 17562864241239740. 2024

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
Salmen, A., Hoepner, R., Fleischer, V., Heldt, M., Gisevius, B., Motte, J., Ruprecht, K., Schneider, R., Fisse, A.L., Grüter, T., Lukas, C., Berthele, A., Giglhuber, K., Flaskamp, M., Mühlau, M., Kirschke, J., Bittner, S., Groppa, S., Lüssi, F., Bayas, A., Meuth, S., Heesen, C., Trebst, C., Wildemann, B., Then Bergh, F., Antony, G., Kümpfel, T., Paul, F., Nischwitz, S., Tumani, H., Zettl, U., Hemmer, B., Wiendl, H., Zipp, F. and Gold, R.
Therapeutic Advances in Neurological Disorders 16 : 17562864231197309. 8 September 2023

Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis.
Chen, J., Alexander, T., Walter-Rittel, T., Ziagaki, A. and Siffrin, V.
Therapeutic Advances in Neurological Disorders 16 : 17562864231182519. 2023

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Stroet, A., Hemmelmann, C., Starck, M., Zettl, U., Doerr, J., Paul, F., Flachenecker, P., Fleischer, V., Zipp, F., Nueckel, H., Kieseier, B.C., Ziegler, A., Gold, R. and Chan, A.
Therapeutic Advances in Neurological Disorders 5 (2): 75-79. March 2012

Review

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon, J.M., Paul, F., Chien, C., Oh, J. and Rotstein, D.L.
Therapeutic Advances in Neurological Disorders 14 : 175628642110143. 9 May 2021

Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.
Jeck, J., Kassubek, R., Coburger, J., Edenhofer, S., Schönsteiner, S.S., Ludolph, A.C., Schmitz, B., Engelke, J., Mayer-Steinacker, R., Lewerenz, J. and Bullinger, L.
Therapeutic Advances in Neurological Disorders 11 : 1756285617753597. 21 January 2018

This list was generated on Sun Nov 24 02:21:20 2024 UTC.
Open Access
MDC Library